Pediatrix Medical Group, Inc.MDNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank29
3Y CAGR-16.0%
Studio
Year-over-Year Change

Price-to-earnings ratio

3Y CAGR
-16.0%/yr
vs +13.5%/yr prior
Acceleration
-29.5pp
Decelerating
Percentile
P29
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
202511.03+199.9%
2024-11.04+14.7%
2023-12.93-169.6%
202218.58+3.5%
202117.96+780.9%
2020-2.64-68.7%
2019-1.56-114.0%
201811.19-27.4%
201715.42-18.7%
201618.96-